These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1637368)

  • 1. Psychoactive drug use in an institution for intellectually handicapped persons.
    Curtis JM
    Med J Aust; 1992 Jan; 156(1):69. PubMed ID: 1637368
    [No Abstract]   [Full Text] [Related]  

  • 2. A clinical pharmacy service to reduce psychotropic medication use in an institution for mentally handicapped persons.
    Inoue F
    Ment Retard; 1982 Apr; 20(2):70-4. PubMed ID: 7078402
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychoactive drug use in an institution for intellectually handicapped persons.
    Sachdev PS
    Med J Aust; 1991 Jul; 155(2):75-9. PubMed ID: 1677447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug use by mentally handicapped persons in institutions and family-replacing residential facilities].
    van Schrojenstein Lantman-de Valk HM; Kessels AG; Haveman MJ; Maaskant MA; Urlings HF; van den Akker M
    Ned Tijdschr Geneeskd; 1995 May; 139(21):1083-8. PubMed ID: 7783802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychoactive drug use in public and community residential facilities for mentally retarded persons.
    Intagliata J; Rinck C
    Psychopharmacol Bull; 1985; 21(2):268-78. PubMed ID: 4001291
    [No Abstract]   [Full Text] [Related]  

  • 6. [How should mentally handicapped adults with depressive disorders be treated psychopharmacologically?].
    Meins W
    Nervenarzt; 1996 Mar; 67(3):216-8. PubMed ID: 8901279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
    Meins W; Auwetter J; Krausz M; Turnier Y
    Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of medication in a residential institution for mentally retarded persons.
    Silva DA
    Ment Retard; 1979 Dec; 17(6):285-8. PubMed ID: 534034
    [No Abstract]   [Full Text] [Related]  

  • 9. Establishing socially validated drug research in community settings.
    Agran M; Martin JE
    Psychopharmacol Bull; 1985; 21(2):285-90. PubMed ID: 3889971
    [No Abstract]   [Full Text] [Related]  

  • 10. Mental retardation. Behavior problems and psychotropic drugs.
    Rothman CB; Chusid E; Giannini MJ
    N Y State J Med; 1979 Apr; 79(5):709-15. PubMed ID: 286168
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment strategies for self-injurious behavior in a large service-delivery network.
    Altmeyer BK; Locke BJ; Griffin JC; Ricketts RW; Williams DE; Mason M; Stark MT
    Am J Ment Defic; 1987 Jan; 91(4):333-40. PubMed ID: 3812603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A national study of prescribed drugs in institutions and community residential facilities for mentally retarded people.
    Hill BK; Balow EA; Bruininks RH
    Psychopharmacol Bull; 1985; 21(2):279-84. PubMed ID: 4001292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Learning disabilities. Challenging service.
    Matthews DR
    Nurs Times; 1995 Jun 7-13; 91(23):59-61. PubMed ID: 7603881
    [No Abstract]   [Full Text] [Related]  

  • 14. Changing patterns of psychoactive drug use with the mentally retarded.
    White AJ
    N Z Med J; 1983 Sep; 96(739):686-8. PubMed ID: 6577342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The psychiatrist in an institution for the social care of mentally handicapped children].
    Drvota S; Müllerová D
    Cesk Pediatr; 1981 Apr; 36(4):203-5. PubMed ID: 7285207
    [No Abstract]   [Full Text] [Related]  

  • 16. Pervasive developmental disorder, behavior problems, and psychotropic drug use in children and adolescents with mental retardation.
    de Bildt A; Mulder EJ; Scheers T; Minderaa RB; Tobi H
    Pediatrics; 2006 Dec; 118(6):e1860-6. PubMed ID: 17142506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of psychoactive drug use among North Dakota group home residents.
    Burd L; Fisher W; Vesely BN; Williams M; Kerbeshian J; Leech C
    Am J Ment Retard; 1991 Sep; 96(2):119-26. PubMed ID: 1930945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring and evaluating psychotropic drug use for persons with mental retardation: a follow-up report.
    Briggs R
    Am J Ment Retard; 1989 May; 93(6):633-9. PubMed ID: 2719846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and prediction of psychotropic drug use in California developmental centers.
    Stone RK; Alvarez WF; Ellman G; Hom AC; White JF
    Am J Ment Retard; 1989 May; 93(6):627-32. PubMed ID: 2719845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in mental health services for people with intellectual disability in residential care in Israel 1998-2004.
    Merrick J; Kandel I; Stawski M
    Isr J Psychiatry Relat Sci; 2006; 43(4):281-4. PubMed ID: 17338448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.